Stephanie Jeske, M.D., Oncologist and Hematologist; Oncology/Hematology Division at Sutter Pacific Medical Foundation

California Pacific CURRENTS: The online journal of CPMC Research Institute

Leading research advances in the treatment of breast cancer

Research Overview

  • Dr. Stephanie Jeske is a board-certified internal medicine specialist, hematologist and oncologist with specific expertise in treating breast cancer.
  • In addition to patient care, Dr. Jeske leads treatment advances through her research into new therapies and optimal management of patients with other solid tumors.
  • Dr. Jeske is a Principal Investigator for National Cancer Institute-sponsored oncology group clinical trials, and industry-sponsored clinical trials.
  • She has authored numerous publications, book chapters and abstracts on emerging treatment options for breast and genitourinary cancers.
  • Dr. Jeske is a Physician Lead in CPMCRI’s Cancer Avatar Project.

Find additional information on oncology research and clinical trials at California Pacific Medical Center.


Training

Dr. Jeske received her M.D. from the Indiana University School of Medicine, Indianapolis, IN. She completed residency training in internal medicine at the University of Texas Southwestern School of Medicine, and a fellowship in oncology clinical research, hematology and oncology at Weill Medical College of Cornell University, New York, NY.

Publication Search

Publications

Tagawa ST, Milowsky MI, Jeske S, Mazumdar M, Kung S, Sung M, Lehrer D, Matulich D, Selzer J, Wright JJ, Nanus DM, A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981. Am J Clin Oncol

Jeske S, Tagawa ST, Olowokure O, Selzer J, Giannakakou P, Nanus DM, Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer. Urol Oncol

Stephanie Jeske, M.D., Oncologist and Hematologist; Oncology/Hematology Division at Sutter Pacific Medical Foundation
Primary Research Interests
  • Clinical trials and research
  • Breast and genitourinary cancers; other solid tumors
  • Immunotherapies and targeted therapies

Cancer Clinical Trials